Vulnerability Description
Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding of any type of vulnerability
CVSS Score
CRITICAL
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Axon | Evidence Sync | 3.15.89 |
References
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/EvidenceExploitThird Party Advisory
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/EvidenceExploitThird Party Advisory
- https://raw.githubusercontent.com/GitHubAssessments/CVE_Assessment_05_2018/masteExploitThird Party Advisory
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/EvidenceExploitThird Party Advisory
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/EvidenceExploitThird Party Advisory
- https://raw.githubusercontent.com/GitHubAssessments/CVE_Assessment_05_2018/masteExploitThird Party Advisory
FAQ
What is CVE-2018-17538?
CVE-2018-17538 is a vulnerability with a CVSS score of 9.8 (CRITICAL). Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding ...
How severe is CVE-2018-17538?
CVE-2018-17538 has been rated CRITICAL with a CVSS base score of 9.8/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2018-17538?
Check the references section above for vendor advisories and patch information. Affected products include: Axon Evidence Sync.